Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans: Review
Morgan, Richard A.
Anderson, W. French
Human Gene Therapy. 1991 Spring; 2(1): 5-14.
The first three approved human clinical trials utilizing retroviral-mediated gene transfer are now underway. While this technology holds great promise for the study and treatment of human disease, it also poses a number of safety concerns. In evaluating clinical protocols, potential complications and the likelihood of their occurrence are estimated by review committees so that a risk/benefit assessment can be made. Current knowledge, reviewed in this article, suggests that no acute complications secondary to retroviral-mediated gene transfer are likely, but the possibility of long-term or unforeseen sequelae in patients suggests the need for post-treatment monitoring.
Showing items related by title, author, creator and subject.
Human Gene Transfer: Characterization of Human Tumor- Infiltrating Lymphocytes as Vehicles for Retroviral-Mediated Gene Transfer in Man Kasid, Attan; Morecki, Shoshana; Aebersold, Paul; Cornetta, Kenneth; Culver, Kenneth; Freeman, Scott; Director, Elaine; Lotze, Michael T.; Blaese, R. Michael; Anderson, W. French; Rosenberg, Steven A. (1990-01)
Gene Transfer Into Humans--Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction Rosenberg, Steven A.; Aebersold, Paul; Cornetta, Kenneth; Kasid, Attan (1990-08-30)